Q2 2019 Holdings
Filed 2019-08-14 | 23 holdings | $17.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $7.0M | 316,316 | 39.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.9M | 60,266 | 38.8% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $3.8M | 52,681 | 21.4% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $12.1K | 152,441 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $12.1K | 470,741 | 0.1% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $11.1K | 294,013 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.8K | 92,380 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $7.6K | 50,317 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $7.5K | 142,305 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $7.3K | 524,140 | 0.0% |
| Pacira BioSciences Inc(PCRX) | COM | 695127100 | $6.5K | 149,086 | 0.0% |
| UroGen Pharma Ltd(URGN) | COM | M96088105 | $6.4K | 176,866 | 0.0% |
| uniQure NV(QURE) | SHS | N90064101 | $4.7K | 59,883 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $4.5K | 230,295 | 0.0% |
| Biohaven Pharmaceutical Holdin(BHVN) | COM | G11196105 | $3.8K | 86,165 | 0.0% |
| Mylan NV | SHS EURO | N59465109 | $2.0K | 102,560 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.9K | 143,665 | 0.0% |
| Regeneron Pharmaceuticals Inc(REGN) | COM | 75886F107 | $1.8K | 5,668 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.6K | 15,423 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $1.3K | 138,102 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $1.3K | 18,697 | 0.0% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $679 | 12,026 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $560 | 3,347 | 0.0% |